X hits on this document

27 views

0 shares

0 downloads

0 comments

2 / 8

VRBPAC 25 February 2011

2010-2011 Influenza Vaccines

Highly successful manufacturing campaign

More doses distributed than ever before

Mid-season indications of significantly increased uptake

Timely strain selection by VRBPAC

Strong production numbers despite moderate yields

Challenges

Completion of pandemic influenza vaccine production

Delayed release for some manufacturers due to late information regarding tip caps

Inconsistent SRID potency values for some manufacturers when using reagents from different sources

Document info
Document views27
Page views27
Page last viewedSat Jan 21 19:27:39 UTC 2017
Pages8
Paragraphs151
Words553

Comments